The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 407.70
Bid: 406.40
Ask: 406.60
Change: 0.00 (0.00%)
Spread: 0.20 (0.049%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 407.70
RTO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q1 Trading Update

19 Apr 2017 07:00

RNS Number : 6538C
Rentokil Initial PLC
19 April 2017
 

RENTOKIL INITIAL PLC (RTO)

FIRST QUARTER TRADING UPDATE

19 April 2017

 

 

(£m)

Q1 2017

Growth

AER

AER

CER

Ongoing Revenue1

579.0

23.8%

10.0%

Revenue

580.0

22.9%

9.2%

 

Overview (CER)

Ongoing Revenue increased by 10.0% in Q1, of which 3.1% was Organic Revenue2 growth (Q1 2016: 2.8%, FY 2016: 3.0%) and 6.9% was from acquisitions. On 16 December 2016 the Company announced the proposed transfer of its workwear and hygiene businesses in Germany and the Benelux to a joint venture (JV) with Haniel. The transaction remains on track to complete by mid-year, subject to competition clearance. Excluding those businesses transferring to the JV the Organic Revenue growth rate was 3.5%. Pest Control grew by 19.1% (5.6% Organic Revenue growth) while Hygiene revenues rose by 3.7% (3.1% Organic Revenue growth). Ongoing Revenue growth in our Emerging and Growth markets has once again been strong, increasing by 24.5% and 12.6% respectively. Our businesses in Manage for Value markets delivered Ongoing Revenue growth of 2.5% while those in the Protect and Enhance markets delivered in line with last year.

 

There has been continuing strong performance in Asia, Pacific, Latin America, the UK and in our largest market, North America. Europe delivered improved Ongoing Revenue growth in Q1, with revenues in France broadly flat year on year.

 

M&AWe have acquired 12 businesses this year to date, ten in Pest Control, one in Hygiene and one in Property Care, principally in Emerging and Growth markets. Combined annualised revenues of the businesses acquired totalled £101.7m in the 12 months immediately prior to acquisition. 

In February we announced the acquisition of Atlanta-based pest control company Allgood Pest Solutions. The business generated annualised revenues for the 12 months prior to acquisition of $26.6m.

Also, as previously announced, in March we completed the transaction to create a joint venture with PCI Pest Control Pvt. Ltd. (PCI), India's largest pest control company, which offers a comprehensive range of pest control services and products through its countrywide network. Rentokil, which has management control of the JV, is integrating its Indian operations into the JV and the combined business has revenues of 4.5bn rupees (c. £50m), will operate from c. 250 locations and employ c. 6,900 people.

On 11 April our JV in the Kingdom of Saudi Arabia (KSA) acquired Sames, the market leader in the commercial pest control sector in KSA with c. 2,500 customers covering most major cities, making us the number one pest control company in KSA and the Gulf Cooperation Council countries. The business generated revenues of £9m in the last 12 months prior to acquisition.

Commenting on today's announcement Andy Ransom, Chief Executive, said:

"We have made a good start to 2017. Pest Control has performed well across the regions and we remain encouraged by the progress we are continuing to deliver in Hygiene. We have been very active in M&A in the first three months of the year, reinforcing our strategy of acquiring high quality pest control and hygiene businesses in Emerging and Growth markets. We are particularly pleased with our JV with PCI in India, which is an outstanding business in a country with significant growth potential for commercial and residential pest control services.

"We are confident that the Company will deliver a performance in line with expectations for 2017."

Enquiries:

 

Investors / Analysts:

Katharine Rycroft

Rentokil Initial plc

07811 270734

Media:

Malcolm Padley

Rentokil Initial plc

07788 978 199

John Sunnucks

Bell Pottinger

0203 772 2549

 

 

AER - actual exchange rates; CER - constant 2016 exchange rates

 

1Ongoing Revenue represents the performance of the continuing operations of the Group (including acquisitions) after removing the effect of disposed or closed businesses.

 

2Organic Revenue represents the growth in Ongoing Revenue excluding the effect of businesses acquired during the year. Acquired businesses are included in organic measures in the year following acquisition, and the comparative period is adjusted to include an estimated full year performance for growth calculations.

 

This announcement contains statements that are, or may be, forward-looking regarding the group's financial position and results, business strategy, plans and objectives. Such statements involve risk and uncertainty because they relate to future events and circumstances and there are accordingly a number of factors which might cause actual results and performance to differ materially from those expressed or implied by such statements. Forward-looking statements speak only as of the date they are made and no representation or warranty, whether expressed or implied, is given in relation to them, including as to their completeness or accuracy or the basis on which they were prepared. Other than in accordance with the Company's legal or regulatory obligations (including under the Listing Rules and the Disclosure and Transparency Rules), the Company does not undertake any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise. Information contained in this announcement relating to the Company or its share price, or the yield on its shares, should not be relied upon as an indicator of future performance. Nothing in this announcement should be construed as a profit forecast.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTMMGMDRRDGNZM
Date   Source Headline
15th Feb 20195:15 pmRNSHolding(s) in Company
1st Feb 20197:00 amRNSChange to Director's details
4th Dec 20187:00 amRNSDefined benefit pension scheme buy-in with PIC
20th Nov 20185:17 pmRNSHolding(s) in Company
16th Nov 20184:14 pmRNSHolding(s) in Company
24th Oct 20182:36 pmRNSDirector/PDMR Shareholding
18th Oct 20187:00 amRNSQ3 Trading Update
2nd Oct 201812:17 pmRNSBlock listing Interim Review
25th Sep 20187:25 amRNSDirector Declaration
13th Sep 20184:43 pmRNSDirector/PDMR Shareholding
29th Aug 20187:00 amRNSDirector/PDMR Shareholding
20th Aug 201812:44 pmRNSDirector/PDMR Shareholding
1st Aug 20183:12 pmRNSHolding(s) in Company
31st Jul 20187:00 amRNSInterim Results
27th Jul 20185:07 pmRNSHolding(s) in Company
5th Jul 20184:52 pmRNSHolding(s) in Company
5th Jul 201811:36 amRNSDirector Declaration
28th Jun 20184:10 pmRNSHolding(s) in Company
7th Jun 20185:16 pmRNSDirector Declaration
17th May 20184:12 pmRNSDirector/PDMR Shareholding
16th May 20187:00 amRNSNotice of Capital Markets Days
9th May 20185:40 pmRNSResult of AGM
4th May 20184:27 pmRNSDirector/PDMR Shareholding
2nd May 201810:52 amRNSDirector/PDMR Shareholding
1st May 20186:00 pmRNSDirector/PDMR Shareholding
30th Apr 20185:48 pmRNSDirector/PDMR Shareholding
26th Apr 20183:24 pmRNSHolding(s) in Company
25th Apr 20184:50 pmRNSHolding(s) in Company
24th Apr 20183:55 pmRNSHolding(s) in Company
24th Apr 201810:53 amRNSHolding(s) in Company
20th Apr 20184:09 pmRNSDirector/PDMR Shareholding
19th Apr 20184:32 pmRNSHolding(s) in Company
19th Apr 20187:00 amRNSQ1 Trading Update
5th Apr 201812:57 pmRNSHolding(s) in Company
5th Apr 201811:06 amRNSAnnual Financial Report
4th Apr 20186:01 pmRNSDirector/PDMR Shareholding
3rd Apr 20184:12 pmRNSBlock listing Interim Review
29th Mar 201811:55 amRNSTotal Voting Rights
27th Mar 20184:01 pmRNSHolding(s) in Company
27th Mar 201812:58 pmRNSAdditional Listing
8th Mar 20185:50 pmRNSDirector/PDMR Shareholding
1st Mar 20187:00 amRNSFinal Results
27th Dec 20177:00 amRNSDirector/PDMR Shareholding
20th Dec 20173:40 pmRNSDirector/PDMR Shareholding
22nd Nov 20174:30 pmRNSHolding(s) in Company
17th Nov 20177:00 amRNSIssue of new EUR400m bond
13th Nov 20174:35 pmRNSHolding(s) in Company
13th Nov 20177:00 amRNSPurchase of Vector Disease Acquisition LLC
7th Nov 20174:14 pmRNSHolding(s) in Company
6th Nov 20177:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.